Journal of the Pediatric Infectious Diseases Society

Journal

Publication Venue For

  • Update From the Advisory Committee on Immunization Practices..  8:379-383. 2019
  • Temporal trends in co-trimoxazole use among children on antiretroviral therapy and the impact of co-trimoxazole on mortality rates in children without severe immunodeficiency.  8:450-460. 2019
  • The burden of congenital cytomegalovirus infection: A prospective cohort study of 20 000 infants in Finland.  8:205-212. 2019
  • Update From the Advisory Committee on Immunization Practices.  7:270-274. 2018
  • Update From the Advisory Committee on Immunization Practices.  7:181-187. 2018
  • Clinical markers and outcomes of neonates with herpes simplex virus deoxyribonucleic acid persistence in cerebrospinal fluid in disseminated and central nervous system infection.  7:E30-E33. 2018
  • Update from the advisory committee on immunization practices.  7:93-99. 2018
  • Delayed recurrence of herpes simplex virus infection in the central nervous system after neonatal infection and completion of six months of suppressive therapy.  6:e177-e179. 2017
  • Update from the advisory committee on immunization practices.  6:311-316. 2017
  • Pharmacokinetics of darunavir/ritonavir with etravirine both twice daily in human immunodeficiency virus-infected adolescents and young adults.  6:294-296. 2017
  • Update from the Advisory Committee on immunization practices.  6:111-115. 2017
  • Pharmacokinetics of once-daily darunavir/ ritonavir with and without etravirine in human immunodeficiency virus-infected children, adolescents, and young adults.  5:131-137. 2016
  • Update from the advisory committee on immunization practices.  5:101-104. 2016
  • Update from the advisory committee on immunization practices.  5:349-355. 2016
  • A randomized, double-blind, placebo-controlled trial of pleconaril for the treatment of neonates with enterovirus sepsis.  5:53-62. 2015
  • Update from the advisory committee on immunization practices.  5:3-6. 2015
  • Pharmacokinetics and 48-week safety and efficacy of raltegravir for oral suspension in human immunodeficiency virus type-1-infected children 4 weeks to 2 years of age.  4:e76-e83. 2015
  • Update from the advisory committee on immunization practices.  4:94-95. 2015
  • Mother-to-child transmission of herpes simplex virus.  3. 2014
  • Update from the advisory committee on immunization practices.  3:282-285. 2014
  • Update from the advisory committee on immunization practices.  3:1-3. 2014
  • Update from the advisory committee on immunization practices.  3:94-97. 2014
  • Executive summary: Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: Recommendations from the national institutes of health, the centers for disease control and prevention, the HIV medicine association of the infectious diseases society of America, the pediatric infectious diseases society, and the American academy of pediatrics.  2:293-308. 2013
  • Update from the advisory committee on immunization practices.  2:309-311. 2013
  • Acyclovir dosing in the neonatal period and beyond.  2:179-182. 2013
  • Eosinophilic appendicitis attributable to strongyloides infection in a pediatric renal transplant patient.  2:274-277. 2013
  • Update from the advisory committee on immunization practices.  2:97-99. 2013
  • International Standard Serial Number (issn)

  • 2048-7193
  • Electronic International Standard Serial Number (eissn)

  • 2048-7207